HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Racial disparities in cancer clinical trials: ‘An old problem with new implications’ Jennifer Byrne
-
- Antihypertensive drugs ‘potentially prolong life’ for patients with colorectal cancer Jennifer R. Southall
- Biomarker testing decisions for lung cancer vary by practice setting Mark Leiser
- Radiation therapy center volume linked to survival among patients with cancer Ryan Lawrence
- COVID-19 pandemic caused more anxiety, treatment delays for people with lung cancer Mark Leiser
- Data support third COVID-19 vaccine dose for some patients with cancer Ryan Lawrence
- Demographic reporting mandates fail to reduce disparities in acute leukemia trials Jennifer R. Southall
- Inaccurate, harmful cancer information prevalent on social media Jennifer Byrne
- Nivolumab plus rucaparib shows ‘noteworthy activity’ in subset of men with prostate cancer Devin McLaughlin
-
- Older adults with late-stage NSCLC benefit from immunotherapy Jennifer R. Southall
- Oncologist to women told they are ‘too loud’: ‘Don’t let anyone dim your passion’ Talitha Bennett
- Second COVID-19 vaccine dose equally effective in people with, without solid cancers Jennifer R. Southall
- ASH to present honorific awards
- Prostate Cancer Foundation names genitourinary oncologist president, CEO
- Foundation presents mentorship awards